These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37522187)

  • 1. Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP).
    Bailey SJ; Bast T; Chaby L; Kinon BJ; Harte MK; Mead S; Moloney RD; Ragan I; Stanford SC; Tricklebank MD; Zervas M; Ajram LA
    J Psychopharmacol; 2023 Nov; 37(11):1051-1057. PubMed ID: 37522187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.
    Tricklebank MD; Robbins TW; Simmons C; Wong EHF
    Psychopharmacology (Berl); 2021 Jun; 238(6):1417-1436. PubMed ID: 33694032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
    Hendriksen H; Groenink L
    Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges for translational psychopharmacology research--some basic principles.
    Miczek KA; de Wit H
    Psychopharmacology (Berl); 2008 Aug; 199(3):291-301. PubMed ID: 18523737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some Reasons Why Preclinical Studies of Psychiatric Disorders Fail to Translate: What Can Be Rescued from the Misunderstanding and Misuse of Animal 'Models'?
    Stanford SC
    Altern Lab Anim; 2020 May; 48(3):106-115. PubMed ID: 32777937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives.
    Persico AM; Arango C; Buitelaar JK; Correll CU; Glennon JC; Hoekstra PJ; Moreno C; Vitiello B; Vorstman J; Zuddas A;
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1513-31. PubMed ID: 26166453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ethics of clinical innovation in psychopharmacology: Challenging traditional bioethics.
    Ghaemi SN; Goodwin FK
    Philos Ethics Humanit Med; 2007 Nov; 2():26. PubMed ID: 17996065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on a 'drug-centred' approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs.
    Moncrieff J
    Epidemiol Psychiatr Sci; 2018 Apr; 27(2):133-140. PubMed ID: 29022518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving clinical trials: American Society of Clinical Psychopharmacology recommendations.
    Klein DF; Thase ME; Endicott J; Adler L; Glick I; Kalali A; Leventer S; Mattes J; Ross P; Bystritsky A
    Arch Gen Psychiatry; 2002 Mar; 59(3):272-8. PubMed ID: 11879165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health psychopharmacology: a new research discipline comes of age?
    Barbui C; Ostuzzi G; Godman B
    Epidemiol Psychiatr Sci; 2018 Feb; 27(1):24-28. PubMed ID: 29322939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology of Williams syndrome: safety, tolerability, and effectiveness.
    Thom RP; Pober BR; McDougle CJ
    Expert Opin Drug Saf; 2021 Mar; 20(3):293-306. PubMed ID: 33369485
    [No Abstract]   [Full Text] [Related]  

  • 15. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.
    Deveaugh-Geiss J; March J; Shapiro M; Andreason PJ; Emslie G; Ford LM; Greenhill L; Murphy D; Prentice E; Roberts R; Silva S; Swanson JM; VAN Zwieten-Boot B; Vitiello B; Wagner KD; Mangum B
    J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):261-270. PubMed ID: 16540810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various current problems in clinical psychopharmacology].
    Smulevich AB; Panteleeva GP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1345-51. PubMed ID: 6637291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety methodology in pediatric psychopharmacology trials.
    Yuill K; Carandang C
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):148-62. PubMed ID: 23607408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail.
    Pound P; Ritskes-Hoitinga M
    J Transl Med; 2018 Nov; 16(1):304. PubMed ID: 30404629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue?
    Drukarch B; Jacobs GE; Wilhelmus MMM
    Biomed Pharmacother; 2020 Oct; 130():110545. PubMed ID: 32731134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. British Association for Psychopharmacology Summer Meeting: 23-26 July 2006, Oxford, United Kingdom.
    Cahir M
    Expert Opin Pharmacother; 2006 Oct; 7(14):2007-10. PubMed ID: 17020426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.